2006 Petris Symposium:
Toward a Health Policy Agenda for All Californians
1:00 pm - 5:00 pm
Berkeley City Club
Panel: The Impact of the Mental Health Services Act on
California's Mental Health System
Panel: The Economics and Policy of Stem Cell Research:
Progress, Set Backs, and the Road Ahead
Agenda
Call to Order & Introduction of Keynote Speakers
Dean Stephen Shortell, PhD, MPH
Blue Cross of California Distinguished Professor of Health Policy and Management,
School of Public Health, University of California, Berkeley*
Keynote Address
Kimberly Belshé, MA
Secretary, California Health and Human Services Agency
"California's Health Coverage Challenges: Prospects for Change"
Keynote Address
Paul B. Ginsburg, PhD
President, Center for Studying Health System Change, Washington DC
"Developments in the U.S. Health Care Market:
Implications for California"
Audience Question & Answer
Moderator:
Dean Stephen Shortell, PhD, MPH
Panel: The Impact of the Mental Health Services Act on
California's Mental Health System
Chair
Kathleen Foote, JD
Senior Assistant Attorney General, California Department of Justice*
Panelists
Timothy T. Brown, PhD
Associate Director of Research,
Nicholas C. Petris Center
Stephen W. Mayberg, PhD
Director, California Department
of Mental Health
Gale Bataille, MSW
San Mateo County Mental Health Director
Audience Question & Answer
Proposition 63, The Mental Health Services Act
Beginning in the early 1990s, California has been moving its public mental health system towards a more integrated and outcome-oriented one, with a focus on consumer empowerment. Realignment legislation, children's system of care, Mentally Ill Offender Crime Reduction (MIOCR) grants, and funding of local mental health grants (AB34/2034) all laid the groundwork for the development and passage of Proposition 63, which is now known as the Mental Health Services Act (MHSA). Passed in November of 2004, it aims to expand access to public mental health services and restructure California's public mental health system into a more consumer-oriented one that addresses a broad continuum of prevention, early intervention, and service needs for the recovery and resiliency of mental health consumers. MHSA's provisions are funded by a 1% tax on incomes over $1 million (affecting approximately 0.1% of California taxpayers). The tax is projected to generate approximately $254 million in fiscal year 2004-05, $683 million in 2005-06, and increasing amounts thereafter. This panel will discuss the implementation process to date, as well as a number of policy issues that have arisen, including questions on involuntary treatment, non-supplantation of existing mental health funds, and concerns with inter-agency collaborations under MHSA.
Panel: The Economics and Policy of Stem Cell Research:
Progress, Set Backs, and the Road Ahead
Chair
Deborah Haas-Wilson, PhD
Professor of Economics, Smith College*
Panelists
Edward E. Penhoet, PhD
President, Gordon and Betty Moore Foundation
Kenneth Taymor, JD
MBV Law LLP, San Francisco
Bruce Cohen, MBA
President and CEO,
Cellerant Therapeutics, Inc., San Carlos
Audience Question & Answer
Proposition 71, The California Stem Cell Research and Cures Initiative
Since August 9, 2001, when President Bush decided to limit federal funds for human embryonic stem cell (HESC) research1, much debate has surfaced about the future of this type of research. In California, Proposition 71, The California Stem Cell Research and Cures Initiative, was passed in November 2005 in response to the federal funding limitations. This bond initiative (1) established the California Institute for Regenerative Medicine, a California surrogate for National Institute of Health, to regulate stem cell research and funding (2) appropriated $3 billion from the General Fund to pay for bonds to finance this endeavor and (3) established a constitutional right to conduct stem cell research. To date, lawsuits have stalled the funding of Proposition 71. Meanwhile, other states have initiated their own stem cell and HESC research projects, and bipartisan Congressional support for HESC research has increased. These events may have substantially decreased California's "first-mover" advantage in HESC research, and others have called into question the economic returns of this bond measure. Many argue that this initiative will not pay for itself as its proponents claimed it would. Diverse groups who support HESC research have questioned the details of this policy experiment, focusing on ethical and oversight questions. Even if therapies are developed, the impact on California's healthcare system and consumers is uncertain and needs careful investigation.
Click here to access the full Petris Center Briefing Paper
1President Discusses Stem Cell Research: http://www.whitehouse.gov/news/releases/2001/08/20010809-2.html. Accessed on April 7, 2006.
Closing Remarks: Richard M. Scheffler, PhD, Director, Nicholas C. Petris Center; Distinguished Professor of Health Economics and Public Policy, University of California, Berkeley*
*Petris Center Advisory Board Member
© 2006 - All photos copyright Peg Skorpinski